Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Parris

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Cancer Research Communications|February 21, 2022
HSP70 inhibition blocks adaptive resistance and synergizes with MEK inhibition for the treatment of NRAS-mutant melanomaJoshua L D Parris, Thibaut Barnoud, Julia I-Ju Leu, et al.
Cancer Discovery|January 11, 2019
Acetyl-CoA Metabolism Supports Multistep Pancreatic TumorigenesisAlessandro Carrer, Sophie Trefely, Steven Zhao, et al.
Structure (London, England : 1993)|June 7, 2003
Catalytically active MAP KAP kinase 2 structures in complex with staurosporine and ADP reveal differences with the autoinhibited enzymeKathryn W Underwood, Kevin D Parris, Elizabeth Federico, et al.
Cancer Research|October 7, 2020
A Novel Inhibitor of HSP70 Induces Mitochondrial Toxicity and Immune Cell Recruitment in TumorsThibaut Barnoud, Jessica C Leung, Julia I-Ju Leu, et al.
Journal of Medicinal Chemistry|September 10, 2020
Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of FructoseKentaro Futatsugi, Aaron C Smith, Meihua Tu, et al.
Journal of Medicinal Chemistry|August 31, 2017
Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK)Kim Huard, Kay Ahn, Paul Amor, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Cancer Research Communications|February 21, 2022
HSP70 inhibition blocks adaptive resistance and synergizes with MEK inhibition for the treatment of NRAS-mutant melanomaJoshua L D Parris, Thibaut Barnoud, Julia I-Ju Leu, et al.
Cancer Discovery|January 11, 2019
Acetyl-CoA Metabolism Supports Multistep Pancreatic TumorigenesisAlessandro Carrer, Sophie Trefely, Steven Zhao, et al.
Structure (London, England : 1993)|June 7, 2003
Catalytically active MAP KAP kinase 2 structures in complex with staurosporine and ADP reveal differences with the autoinhibited enzymeKathryn W Underwood, Kevin D Parris, Elizabeth Federico, et al.
Cancer Research|October 7, 2020
A Novel Inhibitor of HSP70 Induces Mitochondrial Toxicity and Immune Cell Recruitment in TumorsThibaut Barnoud, Jessica C Leung, Julia I-Ju Leu, et al.
Journal of Medicinal Chemistry|September 10, 2020
Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of FructoseKentaro Futatsugi, Aaron C Smith, Meihua Tu, et al.
Journal of Medicinal Chemistry|August 31, 2017
Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK)Kim Huard, Kay Ahn, Paul Amor, et al.
Pageof 3